• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

决奈达隆治疗期间发生中毒性表皮坏死松解症:一种新型抗心律失常药物严重不良事件的首例报告

Toxic Epidermal Necrolysis During Dronedarone Treatment: First Report of a Severe Serious Adverse Event Of A New Antiarrhythmic Drug.

作者信息

Gecks Thomas, Prochnau Dirk, Franz Marcus, Jung Christian, Kühnert Helmut, Schliemann Sibylle, Figulla Hans Rainer

机构信息

Department of Internal Medicine I, Jena University Hospital, Erlanger Allee 101, 07747, Jena, Germany.

Department of Dermatology, Jena University Hospital, Erfurter Straße 35, 07740, Jena, Germany.

出版信息

Cardiovasc Toxicol. 2015 Oct;15(4):399-401. doi: 10.1007/s12012-014-9303-x.

DOI:10.1007/s12012-014-9303-x
PMID:25588686
Abstract

A 77-year-old female patient with symptomatic atrial fibrillation with fast ventricular rate despite conventional antiarrhythmic therapy was treated with dronedarone. Five days later, she developed a maculopapulous exanthema and small flaccid blisters, which spread over the common integument predominantly located on the dorsal trunk. Over few days, the patient showed a severe epidermal necrolysis of approximately 30 % of the body area and ultimately died in multiorgan failure. Here, we report a rare case of toxic epidermal necrolysis during treatment with dronedarone leading to patient death.

摘要

一名77岁女性患者,尽管接受了传统抗心律失常治疗,但仍有症状性房颤且心室率快,接受了决奈达隆治疗。五天后,她出现了斑丘疹和小的松弛水疱,主要分布在躯干背部的普通皮肤表面。几天内,患者出现了约30%体表面积的严重表皮坏死松解,最终死于多器官功能衰竭。在此,我们报告一例决奈达隆治疗期间发生的罕见中毒性表皮坏死松解症导致患者死亡的病例。

相似文献

1
Toxic Epidermal Necrolysis During Dronedarone Treatment: First Report of a Severe Serious Adverse Event Of A New Antiarrhythmic Drug.决奈达隆治疗期间发生中毒性表皮坏死松解症:一种新型抗心律失常药物严重不良事件的首例报告
Cardiovasc Toxicol. 2015 Oct;15(4):399-401. doi: 10.1007/s12012-014-9303-x.
2
Dronedarone for atrial fibrillation therapy.决奈达隆用于心房颤动治疗。
Expert Rev Cardiovasc Ther. 2011 Jun;9(6):675-83. doi: 10.1586/erc.11.58.
3
Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter.决奈达隆用于维持心房颤动或心房扑动的窦性心律。
N Engl J Med. 2007 Sep 6;357(10):987-99. doi: 10.1056/NEJMoa054686.
4
Dronedarone. atrial fibrillation: too many questions about long-term adverse effects.决奈达隆。心房颤动:关于长期不良反应存在诸多疑问。
Prescrire Int. 2010 Aug;19(108):149-52.
5
Dronedarone or amiodarone for rhythm control for atrial fibrillation: implications from the DIONYSOS study.对于心房颤动的节律控制,使用多非利特还是胺碘酮:来自 DIONYSOS 研究的结果。
Expert Opin Pharmacother. 2010 Dec;11(17):2775-8. doi: 10.1517/14656566.2010.517196.
6
Severe toxic hepatitis associated with dronedarone.与决奈达隆相关的严重中毒性肝炎。
Curr Drug Saf. 2013 Jul;8(3):201-2. doi: 10.2174/15748863113089990031.
7
Dronedarone: an emerging therapy for atrial fibrillation.决奈达隆:一种用于心房颤动的新兴疗法。
Ther Adv Cardiovasc Dis. 2010 Jun;4(3):155-64. doi: 10.1177/1753944710366266. Epub 2010 Apr 23.
8
Efficacy and tolerability of dronedarone for patients with atrial fibrillation.盐酸决奈达隆治疗心房颤动的疗效和耐受性。
Cardiol J. 2013;20(5):486-90. doi: 10.5603/CJ.2013.0133.
9
Dronedarone: an overview.盐酸决奈达隆:概述。
Ann Med. 2012 Feb;44(1):60-72. doi: 10.3109/07853890.2011.594808. Epub 2011 Jul 11.
10
A new agent for atrial fibrillation: electrophysiological properties of dronedarone.一种新的心房颤动药物:决奈达隆的电生理特性。
J Cardiovasc Pharmacol Ther. 2010 Dec;15(4 Suppl):6S-14S. doi: 10.1177/1074248410377618.

引用本文的文献

1
Dronedarone-induced photoallergic reaction.决奈达隆诱发的光变应性反应。
JAAD Case Rep. 2020 Oct 12;6(12):1208-1210. doi: 10.1016/j.jdcr.2020.10.003. eCollection 2020 Dec.